SK287152B6 - Použitie dezoxypeganínu na liečenie klinickej depresie - Google Patents

Použitie dezoxypeganínu na liečenie klinickej depresie Download PDF

Info

Publication number: SK287152B6
Authority: SK; Slovakia
Prior art keywords: depression; deoxypeganine; use according; medicament preparation; abuse
Prior art date: 2001-12-21

Application number

SK258-2004A

Other languages

English (en)

Slovak (sk)

Other versions

SK2582004A3 (en

Inventor

Joachim Moormann

Hermann Mucke

Original Assignee

Hf Arzneimittelforschung Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-14

Publication date

2010-01-07

2002-12-14 Application filed by Hf Arzneimittelforschung Gmbh filed Critical Hf Arzneimittelforschung Gmbh

2004-12-01 Publication of SK2582004A3 publication Critical patent/SK2582004A3/sk

2010-01-07 Publication of SK287152B6 publication Critical patent/SK287152B6/sk

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Addiction (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

SK258-2004A 2001-12-21 2002-12-14 Použitie dezoxypeganínu na liečenie klinickej depresie SK287152B6 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10163667A DE10163667B4 (de)	2001-12-21	2001-12-21	Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
PCT/EP2002/014274 WO2003053445A1 (fr)	2001-12-21	2002-12-14	Utilisation de desoxypeganine pour le traitement de la depression clinique

Publications (2)

Publication Number	Publication Date
SK2582004A3 SK2582004A3 (en)	2004-12-01
SK287152B6 true SK287152B6 (sk)	2010-01-07

Family

ID=7710660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK258-2004A SK287152B6 (sk)	2001-12-21	2002-12-14	Použitie dezoxypeganínu na liečenie klinickej depresie

Country Status (29)

Country	Link
US (1)	US20050009813A1 (fr)
EP (1)	EP1461042B1 (fr)
JP (1)	JP2005513105A (fr)
KR (1)	KR100614504B1 (fr)
CN (1)	CN1283253C (fr)
AR (1)	AR037967A1 (fr)
AT (1)	ATE404203T1 (fr)
AU (1)	AU2002363874B2 (fr)
BR (1)	BR0215306A (fr)
CA (1)	CA2471338C (fr)
CZ (1)	CZ301210B6 (fr)
DE (2)	DE10163667B4 (fr)
DK (1)	DK1461042T3 (fr)
EA (1)	EA006896B1 (fr)
ES (1)	ES2312657T3 (fr)
HU (1)	HUP0402298A3 (fr)
IL (2)	IL162509A0 (fr)
MX (1)	MXPA04006125A (fr)
MY (1)	MY138088A (fr)
NO (1)	NO326446B1 (fr)
NZ (1)	NZ533249A (fr)
PL (1)	PL370315A1 (fr)
PT (1)	PT1461042E (fr)
SI (1)	SI1461042T1 (fr)
SK (1)	SK287152B6 (fr)
TW (1)	TWI241189B (fr)
UA (1)	UA76254C2 (fr)
WO (1)	WO2003053445A1 (fr)
ZA (1)	ZA200404053B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE521512C2 (sv) *	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
ES2708552T3 (es) *	2002-12-20	2019-04-10	Niconovum Ab	Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
DE10354894A1 (de) *	2003-11-24	2005-07-07	Hf Arzneimittelforschung Gmbh	Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) *	2003-11-24	2011-03-10	Hf Arzneimittelforschung Gmbh	Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
FR2865650B1 (fr) *	2004-01-30	2008-06-13	Biocortech	Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
JP5000932B2 (ja) *	2005-06-21	2012-08-15	日東電工株式会社	ニコチン含有経皮吸収製剤
WO2007104573A2 (fr)	2006-03-16	2007-09-20	Niconovum Ab	Composition améliorée de tabac à priser
CN101433565B (zh) *	2008-11-26	2013-06-05	上海中医药大学	骆驼蓬属种子总生物碱提取物和它们的制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19906977C1 (de) *	1999-02-19	2000-06-15	Lohmann Therapie Syst Lts	Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) *	1999-02-19	2004-04-15	Lts Lohmann Therapie-Systeme Ag	Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906974C2 (de) *	1999-02-19	2003-10-09	Lohmann Therapie Syst Lts	Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906979B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

2001
- 2001-12-21 DE DE10163667A patent/DE10163667B4/de not_active Expired - Fee Related
2002
- 2002-12-12 MY MYPI20024665A patent/MY138088A/en unknown
- 2002-12-14 MX MXPA04006125A patent/MXPA04006125A/es active IP Right Grant
- 2002-12-14 PT PT02798337T patent/PT1461042E/pt unknown
- 2002-12-14 AU AU2002363874A patent/AU2002363874B2/en not_active Ceased
- 2002-12-14 SK SK258-2004A patent/SK287152B6/sk not_active IP Right Cessation
- 2002-12-14 SI SI200230755T patent/SI1461042T1/sl unknown
- 2002-12-14 UA UA20040604815A patent/UA76254C2/uk unknown
- 2002-12-14 EA EA200400751A patent/EA006896B1/ru not_active IP Right Cessation
- 2002-12-14 KR KR1020047009851A patent/KR100614504B1/ko not_active Expired - Fee Related
- 2002-12-14 BR BR0215306-8A patent/BR0215306A/pt not_active Application Discontinuation
- 2002-12-14 AT AT02798337T patent/ATE404203T1/de active
- 2002-12-14 DK DK02798337T patent/DK1461042T3/da active
- 2002-12-14 HU HU0402298A patent/HUP0402298A3/hu unknown
- 2002-12-14 WO PCT/EP2002/014274 patent/WO2003053445A1/fr not_active Ceased
- 2002-12-14 US US10/496,366 patent/US20050009813A1/en not_active Abandoned
- 2002-12-14 CZ CZ20040739A patent/CZ301210B6/cs not_active IP Right Cessation
- 2002-12-14 IL IL16250902A patent/IL162509A0/xx unknown
- 2002-12-14 CA CA002471338A patent/CA2471338C/fr not_active Expired - Fee Related
- 2002-12-14 NZ NZ533249A patent/NZ533249A/en not_active IP Right Cessation
- 2002-12-14 DE DE50212649T patent/DE50212649D1/de not_active Expired - Lifetime
- 2002-12-14 EP EP02798337A patent/EP1461042B1/fr not_active Expired - Lifetime
- 2002-12-14 ES ES02798337T patent/ES2312657T3/es not_active Expired - Lifetime
- 2002-12-14 JP JP2003554202A patent/JP2005513105A/ja not_active Ceased
- 2002-12-14 PL PL02370315A patent/PL370315A1/xx not_active Application Discontinuation
- 2002-12-14 CN CNB028254031A patent/CN1283253C/zh not_active Expired - Fee Related
- 2002-12-17 TW TW091136439A patent/TWI241189B/zh not_active IP Right Cessation
- 2002-12-20 AR ARP020105056A patent/AR037967A1/es unknown
2004
- 2004-05-25 ZA ZA200404053A patent/ZA200404053B/en unknown
- 2004-06-14 IL IL162509A patent/IL162509A/en not_active IP Right Cessation
- 2004-06-14 NO NO20042476A patent/NO326446B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL162509A (en)	2010-06-16
EA006896B1 (ru)	2006-04-28
NO326446B1 (no)	2008-12-08
KR100614504B1 (ko)	2006-08-22
CN1283253C (zh)	2006-11-08
MXPA04006125A (es)	2005-05-16
AR037967A1 (es)	2004-12-22
DK1461042T3 (da)	2008-12-01
ZA200404053B (en)	2004-10-12
TWI241189B (en)	2005-10-11
HUP0402298A3 (en)	2011-03-28
WO2003053445A8 (fr)	2004-07-01
EP1461042A1 (fr)	2004-09-29
KR20040068327A (ko)	2004-07-30
DE10163667B4 (de)	2006-10-26
CN1604781A (zh)	2005-04-06
IL162509A0 (en)	2005-11-20
BR0215306A (pt)	2004-12-21
HUP0402298A2 (hu)	2005-02-28
CA2471338A1 (fr)	2003-07-03
CZ2004739A3 (cs)	2004-12-15
CZ301210B6 (cs)	2009-12-09
PT1461042E (pt)	2008-11-03
CA2471338C (fr)	2009-02-24
UA76254C2 (en)	2006-07-17
DE50212649D1 (de)	2008-09-25
DE10163667A1 (de)	2003-07-10
HK1066742A1 (zh)	2005-04-01
EP1461042B1 (fr)	2008-08-13
SK2582004A3 (en)	2004-12-01
AU2002363874A1 (en)	2003-07-09
NO20042476L (no)	2004-06-14
ATE404203T1 (de)	2008-08-15
WO2003053445A1 (fr)	2003-07-03
AU2002363874B2 (en)	2007-12-13
TW200301124A (en)	2003-07-01
MY138088A (en)	2009-04-30
PL370315A1 (en)	2005-05-16
US20050009813A1 (en)	2005-01-13
ES2312657T3 (es)	2009-03-01
NZ533249A (en)	2007-05-31
EA200400751A1 (ru)	2004-12-30
SI1461042T1 (sl)	2009-02-28
JP2005513105A (ja)	2005-05-12

Publication	Publication Date	Title
AU2003284005B2 (en)	2009-12-17	Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
US20060122127A1 (en)	2006-06-08	Methods for reducing the side effects associated with mirtzapine treatment
JP2009543767A (ja)	2009-12-10	フリバンセリンとカフェインとを含む組成物、その調製方法及び薬剤としての使用
US20130237526A1 (en)	2013-09-12	Pharmaceutical composition
SK15652003A3 (sk)	2004-04-06	Kombinácia účinných látok na medikamentóznu terapiu návykových alebo omamných prostriedkov
SK284937B6 (sk)	2006-02-02	Použitie prokineticky účinného antiemetika a tramadolu na výrobu liečiva na liečenie migrény
SK287152B6 (sk)	2010-01-07	Použitie dezoxypeganínu na liečenie klinickej depresie
MXPA04006124A (es)	2005-05-16	Cabeza de cilindro.
US6335372B1 (en)	2002-01-01	Treatment of obsessive compulsive disorder
MXPA04006126A (es)	2005-06-08	Acero para herramientas de arranque de viruta.
CA2338326A1 (fr)	2000-02-10	Procedes et compositions pour le traitement et la prevention des toxicomanies a l'aide de moclobemide
JP2007528891A (ja)	2007-10-18	複合鎮痛剤医薬組成物
HK1066742B (en)	2008-11-07	Use of desoxypeganine for treating clinical depression
NZ718978A (en)	2021-08-27	Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
Olszewski	0	Serotonin syndrome
NZ718978B2 (en)	2021-11-30	Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
JP2010222347A (ja)	2010-10-07	Ｐｄｅ５阻害剤及びカルニチンを含有する医薬組成物

Legal Events

Date	Code	Title	Description
2012-09-03	MM4A	Patent lapsed due to non-payment of maintenance fees	Effective date: 20111214